Aperio Technologies
Aperio Technologies, now a digital pathology product line within Leica Biosystems (Danaher Corporation), provides whole-slide imaging scanners, image management software, and AI-enabled analysis tools for hospitals, reference labs, and life sciences research institutions.
- Company typePrivate
- Founded1999
- HeadquartersVista, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
What Aperio Technologies does
Aperio Technologies provides digital pathology imaging systems and workflow software for hospitals, reference laboratories, and pharmaceutical and research institutions. Its core product set is organized around three modules: Scan, comprising whole-slide imaging scanners including the high-throughput Aperio GT Elite and the Aperio AT2; Manage, providing secure and scalable image management and integration software with flexible deployment options; and Analyze, offering computational and AI-enabled image analysis tools for cancer diagnostics and pathological review. The company was founded in 1999 in Vista, California, and historically raised approximately $61.6 million across six venture rounds between 2002 and 2012 before being acquired by Leica Biosystems, where it now operates as a product line. The legal operating entity is Leica Biosystems Nussloch GmbH, headquartered in Nussloch, Germany, with North American business operations at 21440 W. Lake Cook Road, Deer Park, Illinois, and the company is ultimately a subsidiary of Danaher Corporation (NYSE: DHR).
Aperio generates revenue through two streams: hardware sales of whole-slide scanners, and software licenses and subscriptions covering image management, integration, and AI-enabled analysis, sold alongside hardware or as standalone licenses. Pricing is not publicly disclosed and is handled through a consultative enterprise sales motion with quote-based engagement. Marketing is multi-channel, combining educational content through the Knowledge Pathway platform, organic social, webinars, and an email newsletter, while distribution leverages Leica Biosystems' global enterprise field sales and an e-commerce storefront for consumables and IHC primary antibodies. Customer segments center on healthcare providers and pathology laboratories (primary) and life sciences researchers (secondary), with "thousands of implementations worldwide" cited by the company. Strategic innovation partnerships with Abcam, Advanced Cell Diagnostics, Cell Signaling Technology, and Molecular Instruments extend the platform into complementary reagent and molecular assay workflows.
Aperio Technologies firmographics
Firmographics- Name
- Aperio Technologies
- Legal name
- Leica Biosystems Nussloch GmbH
- Website
- https://aperio.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Aperio Technologies, now a digital pathology product line within Leica Biosystems (Danaher Corporation), provides whole-slide imaging scanners, image management software, and AI-enabled analysis tools for hospitals, reference labs, and life sciences research institutions.
- Ownership category
- akta.pro rank
Aperio Technologies industry classification
Industry- Product category
- Digital Pathology Imaging Systems
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Laboratory Analytical Instruments (3826), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Anatomic Pathology LIS & Digital Pathology Workflow (HLACAMAB)
- akta.pro secondary industries
- Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG), Medical Imaging AI (HDAAAEAH), Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays) (HLAAALAO)
Keywords
Where Aperio Technologies is headquartered
LocationHeadquarters
- HQ city
- Vista
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Aperio Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Operations, Personnel, Marketing or Sales, Supply Chain
Revenue model
- Digital Pathology Imaging Systems: Sale of hardware slide scanners (Aperio GT Elite and other models) for whole-slide imaging in pathology labs
- Software Licenses and Subscriptions: Software solutions for image management, integration, and AI-powered image analysis sold alongside hardware or as separate licenses
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
Aperio Technologies product offering
Product offeringCore offering
Aperio Technologies sells whole-slide digital pathology imaging scanners, image management and integration software, and AI-enabled image analysis tools. Its Scan, Manage, and Analyze product lines digitize tissue specimens and enable quantitative, computer-vision-based assessment of pathology images for hospitals, reference laboratories, pharmaceutical companies, and research institutions.
Product overview
Aperio Technologies, now part of Leica Biosystems (a Danaher company), offers a modular digital pathology platform comprising slide scanners (Scan), image management software (Manage), and image analysis solutions (Analyze). The product portfolio centers on the Aperio line of whole slide imaging systems designed for cancer diagnostics and pathological review. The platform supports workflows from translational research to routine clinical diagnostics and AI development, with thousands of implementations worldwide. The Leeds Guide documentation provides implementation guidance for organizations transitioning to digital pathology.
Differentiator
Problem solved
Functional benefit
Brands
- Aperio GT Elite Scanner: High-performance digital pathology slide scanner for clinical and research applications
- Aperio AT2
- Aperio Scan
- Aperio Manage
- Aperio Analyze
Products and services
- Aperio GT Elite Scanner High-performance whole-slide imaging scanner designed for high-throughput laboratory environments with advanced imaging capabilities for digital pathology, serving clinical diagnostics and AI development applications.
- Aperio Digital Pathology Slide Scanners (Scan) High-resolution whole-slide imaging scanners that digitize tissue specimens for digital pathology workflows across translational research, routine diagnostics, and AI development use cases.
- Aperio Digital Pathology Software (Manage) Image management and integration software providing secure, scalable solutions with flexible deployment options and automated system communication for digital pathology image access and workflow.
- Aperio Digital Pathology Image Analysis (Analyze) Computational analysis tools for whole-slide images that enable quantitative assessment and AI-powered analysis of digitized tissue specimens, supporting cancer diagnostics and pathology workflows.
Companies that use Aperio Technologies
Customer profileSegments2 records
Ideal customer profiles2 records
Aperio Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature3 records
Aperio Technologies partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights4 records
Aperio Technologies competitors and assessment
Company assessmentDirect peers
- 3DHistech:
- Hamamatsu Photonics: Hamamatsu's NanoZoomer line is one of the most widely deployed whole-slide imaging scanners globally, directly competing with Aperio Scan for clinical and research pathology installations.
Broad incumbents
- Philips (Digital Pathology / IntelliSite): Philips offers IntelliSite digital pathology solutions including whole-slide scanners and pathology workflow software, competing head-on with Aperio in hospital and reference lab channels as part of its broader health technology portfolio.
- Roche (Ventana Digital Pathology): Roche's Ventana DP 200 scanner and companion diagnostic ecosystem compete directly with Aperio, particularly given Roche's strong position in IHC/ISH staining workflows analogous to Leica's.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Aperio Technologies social profiles
Digital presenceAperio Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Aperio Technologies leadership team
Management profileNumber of profiles
Profiles3 records
Aperio Technologies funding detail
Funding detailFunding overview
Funding rounds6 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Aperio Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Aperio Technologies
What does Aperio Technologies do?
Aperio Technologies sells whole-slide digital pathology imaging scanners, image management and integration software, and AI-enabled image analysis tools. Its Scan, Manage, and Analyze product lines digitize tissue specimens and enable quantitative, computer-vision-based assessment of pathology images for hospitals, reference laboratories, pharmaceutical companies, and research institutions.
Is Aperio Technologies a public or private company?
Aperio Technologies is a private company. It is classified as corporate owned and is currently operating.
When was Aperio Technologies founded?
Aperio Technologies was founded in 1999. It employs 51 to 100 people.
Where is Aperio Technologies based?
Aperio Technologies is headquartered in Vista, United States, in the North America region.
How does Aperio Technologies make money?
Two revenue lines are on record. Digital Pathology Imaging Systems are the primary driver. The others are software Licenses and Subscriptions.
Who are Aperio Technologies's main competitors?
Direct peers on record are 3DHistech and Hamamatsu Photonics. Broad incumbents are Philips (Digital Pathology / IntelliSite) and Roche (Ventana Digital Pathology).
Does Aperio Technologies have an API?
No public API is recorded for Aperio Technologies.
What industry is Aperio Technologies in?
Aperio Technologies's product category is Digital Pathology Imaging Systems. Its primary akta.pro industry code is HLACAMAB, Anatomic Pathology LIS & Digital Pathology Workflow, with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 334516 and its SIC code is 3826.